ECKERT & ZIEGLER SE (EUZ.DE) Stock Fundamental Analysis
Europe - FRA:EUZ - DE0005659700 - Common Stock
16.73 EUR
+1.18 (+7.59%)
Overall EUZ gets a fundamental rating of 7 out of 10. We evaluated EUZ against 60 industry peers in the Health Care Equipment & Supplies industry. EUZ scores excellent points on both the profitability and health parts. This is a solid base for a good stock. EUZ is not valued too expensively and it also shows a decent growth rate. These ratings would make EUZ suitable for quality investing!
1. Profitability
1.1 Basic Checks
EUZ had positive earnings in the past year.
EUZ had a positive operating cash flow in the past year.
In the past 5 years EUZ has always been profitable.
Each year in the past 5 years EUZ had a positive operating cash flow.
1.2 Ratios
With an excellent Return On Assets value of 8.35%, EUZ belongs to the best of the industry, outperforming 81.67% of the companies in the same industry.
EUZ has a Return On Equity of 16.32%. This is amongst the best in the industry. EUZ outperforms 83.33% of its industry peers.
EUZ has a Return On Invested Capital of 12.73%. This is amongst the best in the industry. EUZ outperforms 90.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for EUZ is in line with the industry average of 8.99%.
The 3 year average ROIC (9.92%) for EUZ is below the current ROIC(12.73%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.35% | ||
| ROE | 16.32% | ||
| ROIC | 12.73% |
ROA(3y)6.9%
ROA(5y)7.6%
ROE(3y)13.51%
ROE(5y)14.72%
ROIC(3y)9.92%
ROIC(5y)9.15%
1.3 Margins
EUZ has a Profit Margin of 12.24%. This is in the better half of the industry: EUZ outperforms 76.67% of its industry peers.
EUZ's Profit Margin has declined in the last couple of years.
The Operating Margin of EUZ (21.68%) is better than 90.00% of its industry peers.
In the last couple of years the Operating Margin of EUZ has grown nicely.
Looking at the Gross Margin, with a value of 47.96%, EUZ is in line with its industry, outperforming 43.33% of the companies in the same industry.
EUZ's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 21.68% | ||
| PM (TTM) | 12.24% | ||
| GM | 47.96% |
OM growth 3Y9.05%
OM growth 5Y5.71%
PM growth 3Y-16.23%
PM growth 5Y-1.83%
GM growth 3Y-1.4%
GM growth 5Y-0.15%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so EUZ is creating value.
Compared to 1 year ago, EUZ has about the same amount of shares outstanding.
Compared to 5 years ago, EUZ has more shares outstanding
Compared to 1 year ago, EUZ has an improved debt to assets ratio.
2.2 Solvency
EUZ has an Altman-Z score of 4.81. This indicates that EUZ is financially healthy and has little risk of bankruptcy at the moment.
EUZ has a better Altman-Z score (4.81) than 86.67% of its industry peers.
EUZ has a debt to FCF ratio of 0.86. This is a very positive value and a sign of high solvency as it would only need 0.86 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 0.86, EUZ belongs to the best of the industry, outperforming 88.33% of the companies in the same industry.
A Debt/Equity ratio of 0.18 indicates that EUZ is not too dependend on debt financing.
EUZ has a Debt to Equity ratio of 0.18. This is in the better half of the industry: EUZ outperforms 68.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.18 | ||
| Debt/FCF | 0.86 | ||
| Altman-Z | 4.81 |
ROIC/WACC1.81
WACC7.02%
2.3 Liquidity
A Current Ratio of 3.04 indicates that EUZ has no problem at all paying its short term obligations.
With an excellent Current ratio value of 3.04, EUZ belongs to the best of the industry, outperforming 81.67% of the companies in the same industry.
EUZ has a Quick Ratio of 3.00. This indicates that EUZ is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 3.00, EUZ belongs to the best of the industry, outperforming 90.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.04 | ||
| Quick Ratio | 3 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 16.02% over the past year.
The Earnings Per Share has been growing by 8.65% on average over the past years. This is quite good.
The Revenue has grown by 9.42% in the past year. This is quite good.
The Revenue has been growing by 10.63% on average over the past years. This is quite good.
EPS 1Y (TTM)16.02%
EPS 3Y-1.23%
EPS 5Y8.65%
EPS Q2Q%24.4%
Revenue 1Y (TTM)9.42%
Revenue growth 3Y17.92%
Revenue growth 5Y10.63%
Sales Q2Q%3.66%
3.2 Future
The Earnings Per Share is expected to grow by 16.42% on average over the next years. This is quite good.
Based on estimates for the next years, EUZ will show a quite strong growth in Revenue. The Revenue will grow by 8.27% on average per year.
EPS Next Y30.07%
EPS Next 2Y19.18%
EPS Next 3Y16.42%
EPS Next 5YN/A
Revenue Next Year8.76%
Revenue Next 2Y8.03%
Revenue Next 3Y8.27%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 28.36, EUZ can be considered very expensive at the moment.
The rest of the industry has a similar Price/Earnings ratio as EUZ.
When comparing the Price/Earnings ratio of EUZ to the average of the S&P500 Index (26.34), we can say EUZ is valued inline with the index average.
With a Price/Forward Earnings ratio of 19.02, EUZ is valued on the expensive side.
Compared to the rest of the industry, the Price/Forward Earnings ratio of EUZ indicates a somewhat cheap valuation: EUZ is cheaper than 63.33% of the companies listed in the same industry.
EUZ's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 34.43.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 28.36 | ||
| Fwd PE | 19.02 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, EUZ is valued a bit cheaper than the industry average as 78.33% of the companies are valued more expensively.
EUZ's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. EUZ is cheaper than 80.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 18.72 | ||
| EV/EBITDA | 10.86 |
4.3 Compensation for Growth
EUZ's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The excellent profitability rating of EUZ may justify a higher PE ratio.
A more expensive valuation may be justified as EUZ's earnings are expected to grow with 16.42% in the coming years.
PEG (NY)0.94
PEG (5Y)3.28
EPS Next 2Y19.18%
EPS Next 3Y16.42%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 1.05%, EUZ has a reasonable but not impressive dividend return.
EUZ's Dividend Yield is a higher than the industry average which is at 2.37.
With a Dividend Yield of 1.05, EUZ pays less dividend than the S&P500 average, which is at 2.36.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.05% |
5.2 History
The dividend of EUZ decreases each year by -43.97%.
Dividend Growth(5Y)-43.97%
Div Incr Years1
Div Non Decr Years3
5.3 Sustainability
EUZ pays out 31.30% of its income as dividend. This is a sustainable payout ratio.
DP31.3%
EPS Next 2Y19.18%
EPS Next 3Y16.42%
FRA:EUZ (11/13/2025, 4:01:18 PM)
16.73
+1.18 (+7.59%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners28.66%
Inst Owner ChangeN/A
Ins Owners0.23%
Ins Owner ChangeN/A
Market Cap1.06B
Revenue(TTM)299.27M
Net Income(TTM)36.64M
Analysts82.86
Price Target22.92 (37%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.05% |
Yearly Dividend0.02
Dividend Growth(5Y)-43.97%
DP31.3%
Div Incr Years1
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-66.74%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-65.31%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.59%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 28.36 | ||
| Fwd PE | 19.02 | ||
| P/S | 3.55 | ||
| P/FCF | 18.72 | ||
| P/OCF | 14.18 | ||
| P/B | 4.73 | ||
| P/tB | 5.97 | ||
| EV/EBITDA | 10.86 |
EPS(TTM)0.59
EY3.53%
EPS(NY)0.88
Fwd EY5.26%
FCF(TTM)0.89
FCFY5.34%
OCF(TTM)1.18
OCFY7.05%
SpS4.71
BVpS3.54
TBVpS2.8
PEG (NY)0.94
PEG (5Y)3.28
Graham Number6.85
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.35% | ||
| ROE | 16.32% | ||
| ROCE | 17.92% | ||
| ROIC | 12.73% | ||
| ROICexc | 18.45% | ||
| ROICexgc | 22.68% | ||
| OM | 21.68% | ||
| PM (TTM) | 12.24% | ||
| GM | 47.96% | ||
| FCFM | 18.97% |
ROA(3y)6.9%
ROA(5y)7.6%
ROE(3y)13.51%
ROE(5y)14.72%
ROIC(3y)9.92%
ROIC(5y)9.15%
ROICexc(3y)13.44%
ROICexc(5y)13%
ROICexgc(3y)17.78%
ROICexgc(5y)17.59%
ROCE(3y)13.96%
ROCE(5y)12.89%
ROICexgc growth 3Y11.22%
ROICexgc growth 5Y1.55%
ROICexc growth 3Y17.53%
ROICexc growth 5Y5.68%
OM growth 3Y9.05%
OM growth 5Y5.71%
PM growth 3Y-16.23%
PM growth 5Y-1.83%
GM growth 3Y-1.4%
GM growth 5Y-0.15%
F-Score7
Asset Turnover0.68
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.18 | ||
| Debt/FCF | 0.86 | ||
| Debt/EBITDA | 0.47 | ||
| Cap/Depr | 89.91% | ||
| Cap/Sales | 6.07% | ||
| Interest Coverage | 77.32 | ||
| Cash Conversion | 88.08% | ||
| Profit Quality | 154.92% | ||
| Current Ratio | 3.04 | ||
| Quick Ratio | 3 | ||
| Altman-Z | 4.81 |
F-Score7
WACC7.02%
ROIC/WACC1.81
Cap/Depr(3y)190.39%
Cap/Depr(5y)187.58%
Cap/Sales(3y)10.17%
Cap/Sales(5y)10.1%
Profit Quality(3y)67.54%
Profit Quality(5y)69.62%
High Growth Momentum
Growth
EPS 1Y (TTM)16.02%
EPS 3Y-1.23%
EPS 5Y8.65%
EPS Q2Q%24.4%
EPS Next Y30.07%
EPS Next 2Y19.18%
EPS Next 3Y16.42%
EPS Next 5YN/A
Revenue 1Y (TTM)9.42%
Revenue growth 3Y17.92%
Revenue growth 5Y10.63%
Sales Q2Q%3.66%
Revenue Next Year8.76%
Revenue Next 2Y8.03%
Revenue Next 3Y8.27%
Revenue Next 5YN/A
EBIT growth 1Y12.09%
EBIT growth 3Y28.59%
EBIT growth 5Y16.95%
EBIT Next Year50.24%
EBIT Next 3Y21.7%
EBIT Next 5YN/A
FCF growth 1Y272.16%
FCF growth 3Y114.55%
FCF growth 5Y8.28%
OCF growth 1Y70.09%
OCF growth 3Y25.28%
OCF growth 5Y10.49%
ECKERT & ZIEGLER SE / EUZ.DE FAQ
What is the fundamental rating for EUZ stock?
ChartMill assigns a fundamental rating of 7 / 10 to EUZ.DE.
What is the valuation status for EUZ stock?
ChartMill assigns a valuation rating of 5 / 10 to ECKERT & ZIEGLER SE (EUZ.DE). This can be considered as Fairly Valued.
Can you provide the profitability details for ECKERT & ZIEGLER SE?
ECKERT & ZIEGLER SE (EUZ.DE) has a profitability rating of 8 / 10.
What is the financial health of ECKERT & ZIEGLER SE (EUZ.DE) stock?
The financial health rating of ECKERT & ZIEGLER SE (EUZ.DE) is 9 / 10.
What is the earnings growth outlook for ECKERT & ZIEGLER SE?
The Earnings per Share (EPS) of ECKERT & ZIEGLER SE (EUZ.DE) is expected to grow by 30.07% in the next year.